#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Incidences of community onset severe sepsis, Sepsis-3 sepsis, and bacteremia in Sweden – A prospective population-based study


Autoři: Lars Ljungström aff001;  Rune Andersson aff001;  Gunnar Jacobsson aff001
Působiště autorů: Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden aff001;  Region Västra Götaland, Skaraborg Hospital, Department of Infectious Diseases, Skövde, Sweden aff002;  CARe–Center for Antibiotic Resistance Research, Gothenburg University, Gothenburg, Sweden aff003
Vyšlo v časopise: PLoS ONE 14(12)
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pone.0225700

Souhrn

Background

Sepsis is a major healthcare challenge globally. However, epidemiologic data based on population studies are scarce.

Methods

During a 9-month prospective, population-based study, the Swedish Sepsis-2 criteria were used to investigate the incidence of community onset severe sepsis in adults aged ≥18 years (N = 2,196; mean age, 69; range, 18–102 years). All the patients who were admitted to the hospital and started on intravenous antibiotic treatment within 48 hours were evaluated. Retrospectively the incidence of sepsis according to Sepsis-3 criteria was calculated on this cohort.

Results

The annual incidence of community onset severe sepsis in adults at first admission was 276/100,000 (95% CI, 254–300). The incidence increased more than 40-fold between the youngest and the oldest age group, and was higher for men than for women. The respiratory tract was the most common site of infection (41% of cases). Using the Sepsis-3 criteria, the annual incidence of sepsis was 838/100,000 (95% CI, 798–877), which is 3-fold higher than that of severe sepsis. The main reason for the discrepancy in incidences is the more generous criteria for respiratory dysfunction used in Sepsis-3. Bacteremia was seen in 13% of all the admitted patients, giving an incidence of 203/100,000/year (95%, CI 184–223), which is among the highest incidences reported.

Conclusions

We found a high incidence of community onset severe sepsis, albeit lower than that seen in previous Scandinavian studies. The incidence increased markedly with age of the patient. The incidence of community onset sepsis according to the Sepsis-3 definition is the highest reported to date. It is 3-fold higher than that for severe sepsis, due to more generous criteria for respiratory dysfunction. A very high incidence of bacteremia was noted, partly explained by the high frequency of blood cultures.

Klíčová slova:

Bacterial diseases – Blood – Respiratory infections – Antibiotics – Age groups – Sepsis – Bacteremia – Severe sepsis


Zdroje

1. Fleischmann C, Scherag A, Adhikari N, Hartog C, Tsaganos T, Schlattmann P, et al. Global burden of sepsis: a systematic review. Critical Care. 2015;19(1):P21.

2. Mariansdatter SE, Eiset AH, Søgaard KK, Christiansen CF. Differences in reported sepsis incidence according to study design: a literature review. BMC medical research methodology. 2016;16(1):137. doi: 10.1186/s12874-016-0237-9 27733132

3. Rhee C, Dantes R, Epstein L, Murphy DJ, Seymour CW, Iwashyna TJ, et al. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009–2014. Jama. 2017;318(13):1241–9. doi: 10.1001/jama.2017.13836 28903154

4. Henriksen DP, Laursen CB, Jensen TG, Hallas J, Lassen AT. Incidence rate of community-acquired sepsis among hospitalized acute medical patients—a population-based survey. Critical care medicine. 2015;43(1):13–21. doi: 10.1097/CCM.0000000000000611 25251760

5. Markovic MT, Gottfredsson M, Mitic MT, Gaini S. Epidemiology of community-acquired sepsis in the Faroe Islands–a prospective observational study. Infectious Diseases. 2019;51(1):38–49. doi: 10.1080/23744235.2018.1511056 30460859

6. Mellhammar L, Wullt S, Lindberg Å, Lanbeck P, Christensson B, Linder A, editors. Sepsis incidence: a population-based study. Open forum infectious diseases; 2016: Oxford University Press.

7. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). Jama. 2016;315(8):801–10. doi: 10.1001/jama.2016.0287 26903338

8. Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, et al. Assessment of clinical criteria for sepsis: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Jama. 2016;315(8):762–74. doi: 10.1001/jama.2016.0288 26903335

9. Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, et al. Developing a new definition and assessing new clinical criteria for septic shock: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Jama. 2016;315(8):775–87. doi: 10.1001/jama.2016.0289 26903336

10. Widgren BR, Jourak M. Medical Emergency Triage and Treatment System (METTS): a new protocol in primary triage and secondary priority decision in emergency medicine. The Journal of emergency medicine. 2011;40(6):623–8. doi: 10.1016/j.jemermed.2008.04.003 18930373

11. Ljungström L, Steinum O, Brink M, Gårdlund B, Martner J, Sjölin J. Diagnosis and diagnostic coding of severe sepsis and septic shock. ICD-10 should be completed with additional codes. Lakartidningen. 2011;108(6):276. 21534311

12. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101(6):1644–55. doi: 10.1378/chest.101.6.1644 1303622

13. Ljungström L, Enroth H, Claesson BE, Ovemyr I, Karlsson J, Fröberg B, et al. Clinical evaluation of commercial nucleic acid amplification tests in patients with suspected sepsis. BMC infectious diseases. 2015;15(1):199.

14. Ljungström LR, Jacobsson G, Claesson BE, Andersson R, Enroth H. Respiratory viral infections are underdiagnosed in patients with suspected sepsis. European Journal of Clinical Microbiology & Infectious Diseases. 2017;36(10):1767–76.

15. Ljungström L, Pernestig A-K, Jacobsson G, Andersson R, Usener B, Tilevik D. Diagnostic accuracy of procalcitonin, neutrophil-lymphocyte count ratio, C-reactive protein, and lactate in patients with suspected bacterial sepsis. PloS one. 2017;12(7):e0181704. doi: 10.1371/journal.pone.0181704 28727802

16. Spindler C, Strålin K, Eriksson L, Hjerdt-Goscinski G, Holmberg H, Lidman C, et al. Swedish guidelines on the management of community-acquired pneumonia in immunocompetent adults—Swedish Society of Infectious Diseases 2012. Scandinavian journal of infectious diseases. 2012;44(12):885–902. doi: 10.3109/00365548.2012.700120 22830356

17. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Critical care medicine. 2001;29(7):1303–10.

18. Smith GB, Prytherch DR, Watson D, Forde V, Windsor A, Schmidt PE, et al. SpO2 values in acute medical admissions breathing air—Implications for the British Thoracic Society guideline for emergency oxygen use in adult patients? Resuscitation. 2012;83(10):1201–5.

19. Crapo RO, Jensen RL, Hegewald M, Tashkin DP. Arterial blood gas reference values for sea level and an altitude of 1,400 meters. American Journal of Respiratory and Critical Care Medicine. 1999;160(5):1525–31.

20. Hardie JA, Vollmer WM, Buist AS, Ellingsen I, Mørkve O. Reference values for arterial blood gases in the elderly. Chest. 2004;125(6):2053–60. doi: 10.1378/chest.125.6.2053 15189921

21. Hardie JA, Mørkve O, Ellingsen I. Effect of body position on arterial oxygen tension in the elderly. Respiration. 2002;69(2):123–8. doi: 10.1159/000056314 11961425

22. Shankar-Hari M, Harrison D, Rubenfeld G, Rowan K. Epidemiology of sepsis and septic shock in critical care units: comparison between sepsis-2 and sepsis-3 populations using a national critical care database. BJA: British Journal of Anaesthesia. 2017;119(4):626–36. doi: 10.1093/bja/aex234 29121281

23. Investigators P. A randomized trial of protocol-based care for early septic shock. The New England journal of medicine. 2014;2014(370):1683–93.

24. Investigators A, Group ACT. Goal-directed resuscitation for patients with early septic shock. The New England journal of medicine. 2014;2014(371):1496–506.

25. Forster H, Dempsey J, Thomson J, Vidruk E, DoPico G. Estimation of arterial PO2, PCO2, pH, and lactate from arterialized venous blood. Journal of Applied Physiology. 1972;32(1):134–7. doi: 10.1152/jappl.1972.32.1.134 5007005

26. Contenti J, Corraze H, Lemoël F, Levraut J. Effectiveness of arterial, venous, and capillary blood lactate as a sepsis triage tool in ED patients. The American journal of emergency medicine. 2015;33(2):167–72. doi: 10.1016/j.ajem.2014.11.003 25432592

27. Theerawit P, Na Petvicharn C, Tangsujaritvijit V, Sutherasan Y. The correlation between arterial lactate and venous lactate in patients with sepsis and septic shock. Journal of intensive care medicine. 2018;33(2):116–20. doi: 10.1177/0885066616663169 27502951

28. Holmbom M, Giske CG, Fredrikson M, Balkhed ÅÖ, Claesson C, Nilsson LE, et al. 14-year survey in a Swedish county reveals a pronounced increase in bloodstream infections (BSI). Comorbidity-an independent risk factor for both BSI and mortality. PLoS one. 2016;11(11):e0166527. doi: 10.1371/journal.pone.0166527 27835663

29. Mehl A, Åsvold BO, Kümmel A, Lydersen S, Paulsen J, Haugan I, et al. Trends in antimicrobial resistance and empiric antibiotic therapy of bloodstream infections at a general hospital in Mid-Norway: a prospective observational study. BMC infectious diseases. 2017;17(1):116. doi: 10.1186/s12879-017-2210-6 28148226

30. Nielsen SL, Pedersen C, Jensen T, Gradel K, Kolmos H, Lassen A. Decreasing incidence rates of bacteremia: a 9-year population-based study. Journal of Infection. 2014;69(1):51–9. doi: 10.1016/j.jinf.2014.01.014 24576825

31. Laupland K. Incidence of bloodstream infection: a review of population‐based studies. Clinical microbiology and infection. 2013;19(6):492–500. doi: 10.1111/1469-0691.12144 23398633


Článok vyšiel v časopise

PLOS One


2019 Číslo 12
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#